Phencyclidine-Induced Decrease of Synaptic Connectivity via Inhibition of BDNF Secretion in Cultured Cortical Neurons
Open Access
- 11 March 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 23 (4), 847-858
- https://doi.org/10.1093/cercor/bhs074
Abstract
Repeated administration of phencyclidine (PCP), a noncompetitive N-methyl-D-aspartate (NMDA) receptor blocker, produces schizophrenia-like behaviors in humans and rodents. Although impairment of synaptic function has been implicated in the effect of PCP, the molecular mechanisms have not yet been elucidated. Considering that brain-derived neurotrophic factor (BDNF) plays an important role in synaptic plasticity, we examined whether exposure to PCP leads to impaired BDNF function in cultured cortical neurons. We found that PCP caused a transient increase in the level of intracellular BDNF within 3 h. Despite the increased intracellular amount of BDNF, activation of Trk receptors and downstream signaling cascades, including MAPK/ERK1/2 and PI3K/Akt pathways, were decreased. The number of synaptic sites and expression of synaptic proteins were decreased 48 h after PCP application without any impact on cell viability. Both electrophysiological and biochemical analyses revealed that PCP diminished glutamatergic neurotransmission. Furthermore, we found that the secretion of BDNF from cortical neurons was suppressed by PCP. We also confirmed that PCP-caused downregulation of Trk signalings and synaptic proteins were restored by exogenous BDNF application. It is possible that impaired secretion of BDNF and subsequent decreases in Trk signaling are responsible for the loss of synaptic connections caused by PCP.This publication has 78 references indexed in Scilit:
- Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-γ signaling for glutamate release via a glutamate transporterProceedings of the National Academy of Sciences of the United States of America, 2009
- Target Identification for CNS Diseases by Transcriptional ProfilingNeuropsychopharmacology, 2008
- Neurotrophin-Dependent Dendritic Filopodial Motility: A Convergence on PI3K SignalingJournal of Neuroscience, 2008
- Ethanol–BDNF interactions: Still more questions than answersPharmacology & Therapeutics, 2008
- NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal NeuronsJournal of Neuroscience, 2007
- Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidineProceedings of the National Academy of Sciences of the United States of America, 2007
- Sub-chronic phencyclidine administration increases brain-derived neurotrophic factor in the RAT hippocampusSchizophrenia Research, 2007
- Construction of a mutated pro-nerve growth factor resistant to degradation and suitable for biophysical and cellular utilizationProceedings of the National Academy of Sciences of the United States of America, 2006
- Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceMolecular Psychiatry, 2004
- Developmental change in the nerve growth factor action from induction of choline acetyltransferase to promotion of cell survival in cultured basal forebrain cholinergic neurons from postnatal ratsDevelopmental Brain Research, 1988